Publications by authors named "Takashi Ssuzuki"
Int J Clin Oncol
July 2024
Article Synopsis
- A study evaluated the effectiveness and safety of immune-checkpoint inhibitor combination therapy in 71 patients with unresectable or metastatic esophageal cancer from March 2021 to December 2022.
- The therapy showed a 58% response rate in patients with measurable tumors and an 80% disease control rate overall, with some patients undergoing successful surgery afterward.
- Key factors influencing progression-free survival included patients' performance status and C-reactive protein levels, indicating that those with better health and lower inflammation might benefit most from this treatment.
